Though there are concerns about the increased risk of AKI with SGLT2-Is, pooled results from 8 RCTs found a decrease in risk for AKI (2.64% vs. 3.13%, OR = 0.81; 95% CI 0.74–0.90). This evidence concerns the gene SLC5A2 and acute kidney injury.